US Stock MarketDetailed Quotes

Taysha Gene Therapies (TSHA)

Watchlist
  • 6.400
  • 0.0000.00%
Close Apr 24 16:00 ET
  • 6.400
  • 0.0000.00%
Post 20:01 ET
1.84BMarket Cap-18.82P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Taysha Gene Therapies (TSHA) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
17.28%9.77M
171.27%5.49M
0
78.60%1.99M
-32.51%2.3M
-46.07%8.33M
-43.90%2.02M
-62.33%1.79M
-53.57%1.11M
-27.52%3.41M
Operating revenue
17.28%9.77M
171.27%5.49M
--0
78.60%1.99M
-32.51%2.3M
-46.07%8.33M
-43.90%2.02M
-62.33%1.79M
-53.57%1.11M
-27.52%3.41M
Cost of revenue
Gross profit
Operating expense
26.66%120.27M
53.89%33.79M
48.91%34.02M
28.24%28.74M
-14.48%23.72M
9.36%94.95M
13.16%21.95M
12.11%22.85M
-13.06%22.41M
30.45%27.74M
Selling and administrative expenses
16.98%33.87M
33.25%8.83M
4.77%8.28M
17.17%8.6M
15.16%8.16M
-3.64%28.95M
-1.34%6.63M
-8.00%7.9M
22.55%7.34M
-19.05%7.08M
-General and administrative expense
16.98%33.87M
33.25%8.83M
4.77%8.28M
17.17%8.6M
15.16%8.16M
-3.64%28.95M
-1.34%6.63M
-8.00%7.9M
22.55%7.34M
-19.05%7.08M
Research and development costs
30.91%86.4M
62.82%24.95M
72.25%25.75M
33.62%20.14M
-24.65%15.57M
16.24%66M
20.84%15.33M
26.76%14.95M
-23.84%15.07M
65.07%20.66M
Operating profit
-27.56%-110.5M
-41.98%-28.3M
-61.56%-34.02M
-25.61%-26.75M
11.96%-21.42M
-21.36%-86.62M
-26.18%-19.93M
-34.71%-21.06M
8.92%-21.3M
-46.93%-24.33M
Net non-operating interest income expense
33.97%9.16M
70.32%2.86M
51.42%3.15M
30.36%1.84M
-21.45%1.31M
579.52%6.84M
38.91%1.68M
675.41%2.08M
216.11%1.41M
257.73%1.66M
Non-operating interest income
32.91%9.22M
68.82%2.87M
50.40%3.17M
29.10%1.86M
-21.68%1.33M
94.29%6.94M
-11.50%1.7M
89.99%2.11M
545.74%1.44M
430.72%1.69M
Non-operating interest expense
-38.24%63K
-45.45%12K
-37.50%15K
-37.04%17K
-34.48%19K
-97.96%102K
-96.91%22K
-98.37%24K
-98.13%27K
-97.89%29K
Other net income (expense)
19.52%-7.66M
-353.67%-2.41M
71.54%-1.86M
-89.16%-1.97M
-1.43%-1.42M
75.46%-9.52M
-100.85%-531K
93.52%-6.55M
-34,833.33%-1.04M
-17,337.50%-1.4M
Gain on sale of security
-7,593.75%-1.2M
-986.75%-736K
-489.33%-292K
-240.00%-273K
130.27%102K
100.05%16K
-99.87%83K
100.07%75K
--195K
---337K
Special income (charges)
--0
--0
--0
----
----
-96.43%-4.84M
--0
-685.39%-4.84M
----
----
-Less:Impairment of capital assets
--0
--0
--0
----
----
354.27%4.84M
--0
685.39%4.84M
----
----
Other non- operating income (expenses)
-37.63%-6.46M
-172.48%-1.67M
11.94%-1.57M
-37.27%-1.7M
-43.38%-1.52M
-196.09%-4.69M
60.67%-614K
-9,289.47%-1.78M
-41,333.33%-1.24M
-13,125.00%-1.06M
Income before tax
-22.06%-109M
-48.26%-27.85M
-28.24%-32.73M
-28.45%-26.88M
10.52%-21.53M
19.96%-89.3M
-139.35%-18.79M
78.20%-25.52M
14.92%-20.93M
-36.54%-24.06M
Income tax
Net income
-22.06%-109M
-48.26%-27.85M
-28.24%-32.73M
-28.45%-26.88M
10.52%-21.53M
19.96%-89.3M
-139.35%-18.79M
78.20%-25.52M
14.92%-20.93M
-36.54%-24.06M
Net income continuous Operations
-22.06%-109M
-48.26%-27.85M
-28.24%-32.73M
-28.45%-26.88M
10.52%-21.53M
19.96%-89.3M
-139.35%-18.79M
78.20%-25.52M
14.92%-20.93M
-36.54%-24.06M
Minority interest income
Net income attributable to the parent company
-22.06%-109M
-48.26%-27.85M
-28.24%-32.73M
-28.45%-26.88M
10.52%-21.53M
19.96%-89.3M
-139.35%-18.79M
78.20%-25.52M
14.92%-20.93M
-36.54%-24.06M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-22.06%-109M
-48.26%-27.85M
-28.24%-32.73M
-28.45%-26.88M
10.52%-21.53M
19.96%-89.3M
-139.35%-18.79M
78.20%-25.52M
14.92%-20.93M
-36.54%-24.06M
Basic earnings per share
5.56%-0.34
-14.29%-0.08
10.00%-0.09
0.00%-0.09
20.00%-0.08
62.50%-0.36
-127.41%-0.07
89.25%-0.1
76.32%-0.09
64.29%-0.1
Diluted earnings per share
5.56%-0.34
-14.29%-0.08
10.00%-0.09
0.00%-0.09
20.00%-0.08
62.50%-0.36
-127.41%-0.07
89.25%-0.1
76.32%-0.09
64.29%-0.1
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 17.28%9.77M171.27%5.49M078.60%1.99M-32.51%2.3M-46.07%8.33M-43.90%2.02M-62.33%1.79M-53.57%1.11M-27.52%3.41M
Operating revenue 17.28%9.77M171.27%5.49M--078.60%1.99M-32.51%2.3M-46.07%8.33M-43.90%2.02M-62.33%1.79M-53.57%1.11M-27.52%3.41M
Cost of revenue
Gross profit
Operating expense 26.66%120.27M53.89%33.79M48.91%34.02M28.24%28.74M-14.48%23.72M9.36%94.95M13.16%21.95M12.11%22.85M-13.06%22.41M30.45%27.74M
Selling and administrative expenses 16.98%33.87M33.25%8.83M4.77%8.28M17.17%8.6M15.16%8.16M-3.64%28.95M-1.34%6.63M-8.00%7.9M22.55%7.34M-19.05%7.08M
-General and administrative expense 16.98%33.87M33.25%8.83M4.77%8.28M17.17%8.6M15.16%8.16M-3.64%28.95M-1.34%6.63M-8.00%7.9M22.55%7.34M-19.05%7.08M
Research and development costs 30.91%86.4M62.82%24.95M72.25%25.75M33.62%20.14M-24.65%15.57M16.24%66M20.84%15.33M26.76%14.95M-23.84%15.07M65.07%20.66M
Operating profit -27.56%-110.5M-41.98%-28.3M-61.56%-34.02M-25.61%-26.75M11.96%-21.42M-21.36%-86.62M-26.18%-19.93M-34.71%-21.06M8.92%-21.3M-46.93%-24.33M
Net non-operating interest income expense 33.97%9.16M70.32%2.86M51.42%3.15M30.36%1.84M-21.45%1.31M579.52%6.84M38.91%1.68M675.41%2.08M216.11%1.41M257.73%1.66M
Non-operating interest income 32.91%9.22M68.82%2.87M50.40%3.17M29.10%1.86M-21.68%1.33M94.29%6.94M-11.50%1.7M89.99%2.11M545.74%1.44M430.72%1.69M
Non-operating interest expense -38.24%63K-45.45%12K-37.50%15K-37.04%17K-34.48%19K-97.96%102K-96.91%22K-98.37%24K-98.13%27K-97.89%29K
Other net income (expense) 19.52%-7.66M-353.67%-2.41M71.54%-1.86M-89.16%-1.97M-1.43%-1.42M75.46%-9.52M-100.85%-531K93.52%-6.55M-34,833.33%-1.04M-17,337.50%-1.4M
Gain on sale of security -7,593.75%-1.2M-986.75%-736K-489.33%-292K-240.00%-273K130.27%102K100.05%16K-99.87%83K100.07%75K--195K---337K
Special income (charges) --0--0--0---------96.43%-4.84M--0-685.39%-4.84M--------
-Less:Impairment of capital assets --0--0--0--------354.27%4.84M--0685.39%4.84M--------
Other non- operating income (expenses) -37.63%-6.46M-172.48%-1.67M11.94%-1.57M-37.27%-1.7M-43.38%-1.52M-196.09%-4.69M60.67%-614K-9,289.47%-1.78M-41,333.33%-1.24M-13,125.00%-1.06M
Income before tax -22.06%-109M-48.26%-27.85M-28.24%-32.73M-28.45%-26.88M10.52%-21.53M19.96%-89.3M-139.35%-18.79M78.20%-25.52M14.92%-20.93M-36.54%-24.06M
Income tax
Net income -22.06%-109M-48.26%-27.85M-28.24%-32.73M-28.45%-26.88M10.52%-21.53M19.96%-89.3M-139.35%-18.79M78.20%-25.52M14.92%-20.93M-36.54%-24.06M
Net income continuous Operations -22.06%-109M-48.26%-27.85M-28.24%-32.73M-28.45%-26.88M10.52%-21.53M19.96%-89.3M-139.35%-18.79M78.20%-25.52M14.92%-20.93M-36.54%-24.06M
Minority interest income
Net income attributable to the parent company -22.06%-109M-48.26%-27.85M-28.24%-32.73M-28.45%-26.88M10.52%-21.53M19.96%-89.3M-139.35%-18.79M78.20%-25.52M14.92%-20.93M-36.54%-24.06M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -22.06%-109M-48.26%-27.85M-28.24%-32.73M-28.45%-26.88M10.52%-21.53M19.96%-89.3M-139.35%-18.79M78.20%-25.52M14.92%-20.93M-36.54%-24.06M
Basic earnings per share 5.56%-0.34-14.29%-0.0810.00%-0.090.00%-0.0920.00%-0.0862.50%-0.36-127.41%-0.0789.25%-0.176.32%-0.0964.29%-0.1
Diluted earnings per share 5.56%-0.34-14.29%-0.0810.00%-0.090.00%-0.0920.00%-0.0862.50%-0.36-127.41%-0.0789.25%-0.176.32%-0.0964.29%-0.1
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -